In Vivo Imaging of β-Amyloid Plaques in Alzheimer's Disease Brains.

阿尔茨海默病大脑中 β-淀粉样斑块的体内成像。

基本信息

  • 批准号:
    15390014
  • 负责人:
  • 金额:
    $ 7.49万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2003
  • 资助国家:
    日本
  • 起止时间:
    2003 至 2005
  • 项目状态:
    已结题

项目摘要

Formation and accumulation of β-amyloid (Aβ) peptide aggregates in the brain are critical factors in the development and progression of Alzheimer's disease (AD). In vivo imaging of amyloid plaques may lead to early detection of AD and monitoring the progression and effectiveness of AD treatment. In vivo imaging probes, showing high binding affinity for Aβ aggregates, and high brain penetrations, are essential for imaging of amyloid plaques in Alzheimer's disease. Recently, many agents based on Congo red and thioflavin have been reported as potential imaging agents. We have synthesized and evaluated benzofuran and stilbene derivatives labeled with ^<123>I and ^<11>C as PET and SPECT probes for imaging amyloid plaques in Alzheimer's disease. The results has prompted us to further search for effective and more practical amyloid imaging probe having a noble core structure.It has been previously shown that some flavones may have binding affinity to amyloid plaques in research into the mecha … More nism behind the anti-amyloidogenic activity of flavones. In this study, a series of flavone derivatives was designed and synthesized. Preparation of radioiodinated flavone was carried out by an iododestannylation reaction catalyzed by hydrogen peroxide. The log PC value of these flavones varied from 1.9 to 2.7, spanning the optimum range. The binding affinities for amyloid plaques were assessed by in vitro binding assay using pre-formed synthetic Aβ aggregates. The binding affinities of some compounds for Aβ (1-40) and Aβ (1-42) aggregates varied from 13nM to 77nM. When in vitro plaque labeling was carried out using post-mortem AD brain sections, all flavones intensely stained not only, amyloid plaques, but also cerebrovascular amyloids. The in vivo pharmacokinetic properties of radioiodinated flavone derivatives were evaluated in normal mice with standard biodistribution studies. Several compounds displayed high brain uptakes ranging from 3.2 to 4.1%ID/g at 2min post injection. The radioactivity was washed out from the brain rapidly (0.5-1.9%ID/g at 30min), which is highly desirable for amyloid imaging agents. These results suggest that the classes of radioiodinated flavones may be useful candidates as potential imaging agents for amyloid plaques. Less
脑内β-淀粉样蛋白(Aβ)聚集体的形成和积累是阿尔茨海默病(AD)发生发展的关键因素。淀粉样蛋白斑块的体内成像可能导致AD的早期检测和监测AD治疗的进展和有效性。显示出对Aβ聚集体的高结合亲和力和高脑穿透性的体内成像探针对于阿尔茨海默病中淀粉样蛋白斑块的成像是必不可少的。近年来,许多基于刚果红和硫磺素的药物被报道为潜在的显像剂。我们已经合成并评估了苯并呋喃和二苯乙烯衍生物标记的^<123>I和^<11>C作为PET和SPECT探针成像淀粉样斑块在阿尔茨海默病。这一结果促使我们进一步寻找有效的、更实用的、具有高贵核心结构的淀粉样蛋白成像探针。 ...更多信息 黄酮抗淀粉样蛋白生成活性背后的机理。本研究设计并合成了一系列黄酮衍生物。以过氧化氢为催化剂,通过碘代脱锡反应制备了放射性碘标记黄酮。这些黄酮的log PC值从1.9到2.7不等,跨越了最佳范围。通过使用预形成的合成Aβ聚集体的体外结合测定来评估淀粉样蛋白斑块的结合亲和力。某些化合物对Aβ(1-40)和Aβ(1-42)聚集体的结合亲和力在13 nM至77 nM之间变化。当使用死后AD脑切片进行体外斑块标记时,所有黄酮不仅强烈染色淀粉样斑块,而且还染色脑血管淀粉样蛋白。放射性碘标记的黄酮衍生物的体内药代动力学特性进行了评价,在正常小鼠与标准的生物分布研究。几种化合物在注射后2分钟显示出范围为3.2至4.1%ID/g的高脑摄取。放射性迅速从脑中洗出(30分钟时0.5-1.9%ID/g),这对于淀粉样蛋白成像剂是高度期望的。这些结果表明,类放射性碘标记的黄酮可能是有用的候选人作为淀粉样斑块的潜在显像剂。少

项目成果

期刊论文数量(36)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Akizawa Hiromichi: "Effect of carboxylation of N-terminal phenylalanine of ^<111>In-DTPA (diethylenetri aminepentaacetic acid)-octreotide on accumulation of radioactivity in kidney"Biological & Pharmaceutical Bulletin. 27・2. 271-272 (2004)
Hiromichi Akizawa:“^<111>In-DTPA(二亚乙基三胺五乙酸)-奥曲肽的 N 末端苯丙氨酸的羧化对肾脏中放射性蓄积的影响”《生物与制药通报》27・2(2004)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
アミロイド関連疾患診断用組成物
用于诊断淀粉样蛋白相关疾病的组合物
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Uehara Tomoya: "In vivo recognition of cyclopentadienyltricarbonylrhenium (CpTR) derivatives"Nuclear Medicine and Biol. 30. 327-333 (2003)
上原朋也:“环戊二烯基三羰基铼(CpTR)衍生物的体内识别”核医学与生物学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Effect of carboxylation of N-terminal phenylalanine of In^^111-DTPA (diethylenetriaminepentaacetic acid)-octreotide on accumulation of radioactivity in kidney.
In^^111-DTPA(二亚乙基三胺五乙酸)-奥曲肽 N 端苯丙氨酸羧化对肾脏放射性蓄积的影响。
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    H.Akizawa;H.Takimoto;M.Saito;A.Iwado;M.Mifune;Y.saito;T.Uehara;Y.Arano;T.Mukai;H.Hanaoka;H.Saji
  • 通讯作者:
    H.Saji
A new hydroxamamide-based ligand system for Tc^^99m labeling for proteine and peptides
一种新的基于羟肟酰胺的配体系统,用于蛋白质和肽的 Tc^^99m 标记
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NAKAYAMA Morio其他文献

NAKAYAMA Morio的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NAKAYAMA Morio', 18)}}的其他基金

Development of a unified producing system for various 68Ga-radiopharmaceuticals based on the characteristics of novel 68Ge/68Ga generator.
基于新型68Ge/68Ga发生器的特点,开发了多种68Ga放射性药物的统一生产系统。
  • 批准号:
    16H05392
  • 财政年份:
    2016
  • 资助金额:
    $ 7.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of multimodal imaging probes targeting survivin.
开发针对生存素的多模态成像探针。
  • 批准号:
    16K15585
  • 财政年份:
    2016
  • 资助金额:
    $ 7.49万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Development of molecular probe for SPECT imaging of amyloid in the brain
开发脑部淀粉样蛋白 SPECT 成像分子探针
  • 批准号:
    21390348
  • 财政年份:
    2009
  • 资助金额:
    $ 7.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of production-system of PET imaging agents without cyclotron.
开发无回旋加速器的PET显像剂生产系统。
  • 批准号:
    18390015
  • 财政年份:
    2006
  • 资助金额:
    $ 7.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Construction of lipid bilayer membrane on ion-exchange resin surface and the application as separation material
离子交换树脂表面脂质双层膜的构建及其作为分离材料的应用
  • 批准号:
    11672146
  • 财政年份:
    1999
  • 资助金额:
    $ 7.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of ^<99m>Tc-complexes for imaging cancer metastasis
用于癌症转移成像的^<99m>Tc复合物的开发
  • 批准号:
    09672190
  • 财政年份:
    1997
  • 资助金额:
    $ 7.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Preparation of ^<99m>Tc radiopharmaceuticals using macroreticular Sn (II) complex
大网状Sn(II)络合物制备^<99m>Tc放射性药物
  • 批准号:
    04557104
  • 财政年份:
    1992
  • 资助金额:
    $ 7.49万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)
Developement of New Polymer Membranes for Separation
新型聚合物分离膜的开发
  • 批准号:
    60550644
  • 财政年份:
    1985
  • 资助金额:
    $ 7.49万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Molecular imaging of RIPK1/necroptosis as a key biomarker in Alzheimer's disease
RIPK1/坏死性凋亡作为阿尔茨海默病关键生物标志物的分子成像
  • 批准号:
    10378615
  • 财政年份:
    2020
  • 资助金额:
    $ 7.49万
  • 项目类别:
Molecular imaging of PS1/gamma-secretase and analysis of Alzheimer's disease.
PS1/γ-分泌酶的分子成像和阿尔茨海默病的分析。
  • 批准号:
    9901420
  • 财政年份:
    2019
  • 资助金额:
    $ 7.49万
  • 项目类别:
Copper Radiopharmaceuticals for Molecular Imaging of Alzheimer's Disease
用于阿尔茨海默病分子成像的铜放射性药物
  • 批准号:
    DP0773135
  • 财政年份:
    2008
  • 资助金额:
    $ 7.49万
  • 项目类别:
    Discovery Projects
Development of molecular imaging probes for β-amyloid and tau in Alzheimer's disease
开发阿尔茨海默病中 β-淀粉样蛋白和 tau 蛋白的分子成像探针
  • 批准号:
    20689023
  • 财政年份:
    2008
  • 资助金额:
    $ 7.49万
  • 项目类别:
    Grant-in-Aid for Young Scientists (A)
Magnetic Resonance Molecular Imaging Studies of Alzheimer's Disease
阿尔茨海默病的磁共振分子成像研究
  • 批准号:
    8061965
  • 财政年份:
    2007
  • 资助金额:
    $ 7.49万
  • 项目类别:
Magnetic Resonance Molecular Imaging Studies of Alzheimer's Disease
阿尔茨海默病的磁共振分子成像研究
  • 批准号:
    7612088
  • 财政年份:
    2007
  • 资助金额:
    $ 7.49万
  • 项目类别:
Magnetic Resonance Molecular Imaging Studies of Alzheimer's Disease
阿尔茨海默病的磁共振分子成像研究
  • 批准号:
    7473114
  • 财政年份:
    2007
  • 资助金额:
    $ 7.49万
  • 项目类别:
Magnetic Resonance Molecular Imaging Studies of Alzheimer's Disease
阿尔茨海默病的磁共振分子成像研究
  • 批准号:
    7321368
  • 财政年份:
    2007
  • 资助金额:
    $ 7.49万
  • 项目类别:
Basic research of molecular imaging for early diagnosis of Alzheimer's disease
阿尔茨海默病早期诊断的分子影像基础研究
  • 批准号:
    18591369
  • 财政年份:
    2006
  • 资助金额:
    $ 7.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The development of radiolabeled molecular imaging agents for diagnosing Alzheimer's disease.
用于诊断阿尔茨海默病的放射性标记分子成像剂的开发。
  • 批准号:
    14570845
  • 财政年份:
    2002
  • 资助金额:
    $ 7.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了